Literature DB >> 33716466

Correspondence to: Management of Venous Thromboembolisms: Part II. The Consensus for Pulmonary Embolism and Updates.

Yu-Yun Shao1,2, Hung-Ju Lin3.   

Abstract

Entities:  

Keywords:  Anticoagulation; Cancer; Deep vein thrombosis; Pulmonary embolism

Year:  2021        PMID： 33716466      PMCID： PMC7953113          DOI： 10.6515/ACS.202103_37(2).20210118B

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN： 1011-6842            Impact factor:   2.672


× No keyword cloud information.
  9 in total

1.  Apixaban to Prevent Venous Thromboembolism in Patients with Cancer.

Authors:  Marc Carrier; Karim Abou-Nassar; Ranjeeta Mallick; Vicky Tagalakis; Sudeep Shivakumar; Ariah Schattner; Philip Kuruvilla; Danny Hill; Silvana Spadafora; Katerine Marquis; Mateya Trinkaus; Anna Tomiak; Agnes Y Y Lee; Peter L Gross; Alejandro Lazo-Langner; Robert El-Maraghi; Glenwood Goss; Gregoire Le Gal; David Stewart; Timothy Ramsay; Marc Rodger; Debra Witham; Philip S Wells
Journal:  N Engl J Med       Date:  2018-12-04       Impact factor: 91.245

2.  A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts.

Authors:  Ingrid Pabinger; Nick van Es; Georg Heinze; Florian Posch; Julia Riedl; Eva-Maria Reitter; Marcello Di Nisio; Gabriela Cesarman-Maus; Noémie Kraaijpoel; Christoph Carl Zielinski; Harry Roger Büller; Cihan Ay
Journal:  Lancet Haematol       Date:  2018-06-07       Impact factor: 18.959

3.  Development and validation of a predictive model for chemotherapy-associated thrombosis.

Authors:  Alok A Khorana; Nicole M Kuderer; Eva Culakova; Gary H Lyman; Charles W Francis
Journal:  Blood       Date:  2008-01-23       Impact factor: 22.113

4.  Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update.

Authors:  Nigel S Key; Alok A Khorana; Nicole M Kuderer; Kari Bohlke; Agnes Y Y Lee; Juan I Arcelus; Sandra L Wong; Edward P Balaban; Christopher R Flowers; Charles W Francis; Leigh E Gates; Ajay K Kakkar; Mark N Levine; Howard A Liebman; Margaret A Tempero; Gary H Lyman; Anna Falanga
Journal:  J Clin Oncol       Date:  2019-08-05       Impact factor: 44.544

5.  Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.

Authors:  Gary E Raskob; Nick van Es; Peter Verhamme; Marc Carrier; Marcello Di Nisio; David Garcia; Michael A Grosso; Ajay K Kakkar; Michael J Kovacs; Michele F Mercuri; Guy Meyer; Annelise Segers; Minggao Shi; Tzu-Fei Wang; Erik Yeo; George Zhang; Jeffrey I Zwicker; Jeffrey I Weitz; Harry R Büller
Journal:  N Engl J Med       Date:  2017-12-12       Impact factor: 91.245

6.  Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.

Authors:  Alok A Khorana; Gerald A Soff; Ajay K Kakkar; Saroj Vadhan-Raj; Hanno Riess; Ted Wun; Michael B Streiff; David A Garcia; Howard A Liebman; Chandra P Belani; Eileen M O'Reilly; Jai N Patel; Habte A Yimer; Peter Wildgoose; Paul Burton; Ujjwala Vijapurkar; Simrati Kaul; John Eikelboom; Robert McBane; Kenneth A Bauer; Nicole M Kuderer; Gary H Lyman
Journal:  N Engl J Med       Date:  2019-02-21       Impact factor: 176.079

7.  Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer.

Authors:  Giancarlo Agnelli; Cecilia Becattini; Guy Meyer; Andres Muñoz; Menno V Huisman; Jean M Connors; Alexander Cohen; Rupert Bauersachs; Benjamin Brenner; Adam Torbicki; Maria R Sueiro; Catherine Lambert; Gualberto Gussoni; Mauro Campanini; Andrea Fontanella; Giorgio Vescovo; Melina Verso
Journal:  N Engl J Med       Date:  2020-03-29       Impact factor: 91.245

8.  Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D).

Authors:  Annie M Young; Andrea Marshall; Jenny Thirlwall; Oliver Chapman; Anand Lokare; Catherine Hill; Danielle Hale; Janet A Dunn; Gary H Lyman; Charles Hutchinson; Peter MacCallum; Ajay Kakkar; F D Richard Hobbs; Stavros Petrou; Jeremy Dale; Christopher J Poole; Anthony Maraveyas; Mark Levine
Journal:  J Clin Oncol       Date:  2018-05-10       Impact factor: 44.544
  9 in total
  1 in total

1.  2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.

Authors:  Tzung-Dau Wang; Chern-En Chiang; Ting-Hsing Chao; Hao-Min Cheng; Yen-Wen Wu; Yih-Jer Wu; Yen-Hung Lin; Michael Yu-Chih Chen; Kwo-Chang Ueng; Wei-Ting Chang; Ying-Hsiang Lee; Yu-Chen Wang; Pao-Hsien Chu; Tzu-Fan Chao; Hsien-Li Kao; Charles Jia-Yin Hou; Tsung-Hsien Lin
Journal:  Acta Cardiol Sin       Date:  2022-05       Impact factor: 1.800
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.